Quick Answer
Pelthos Therapeutics Inc. reported Total Revenue of $16.80 million for the year ending 2025.
- This data is from Pelthos Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2025: $294.0 thousand | Q3 2025: $7.41 million.
- Historical annual values: Fiscal year 2025: $16.80 million | Fiscal year 2024: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: